Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 醫學檢驗暨生物技術學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/69839
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor鄧麗珍(Lee-Jene Teng)
dc.contributor.authorHsin-Ni Huangen
dc.contributor.author黃心妮zh_TW
dc.date.accessioned2021-06-17T03:30:17Z-
dc.date.available2021-03-07
dc.date.copyright2018-03-07
dc.date.issued2018
dc.date.submitted2018-02-22
dc.identifier.citation1. Chen CJ and Huang YC. New epidemiology of Staphylococcus aureus infection in Asia. Clin Microbiol Infect. 2014; 20(7):605-623.
2. Rollins BJ. Chemokines. Blood. 1997; 90(3):909-928.
3. Belkaid Y and Tamoutounour S. The influence of skin microorganisms on cutaneous immunity. Nat Rev Immunol. 2016; 16(6):353-366.
4. Kim HK, Thammavongsa V, Schneewind O and Missiakas D. Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr Opin Microbiol. 2012; 15(1):92-99.
5. Sharon J. Peacock IdSaFDL. What determines nasal carriage of
Staphylococcus aureus?
6. Vandenesch F, Lina G and Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol. 2012; 2:12.
7. van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP and van Strijp JA. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol. 2006; 188(4):1310-1315.
8. Salgado-Pabon W, Herrera A, Vu BG, Stach CS, Merriman JA, Spaulding AR and Schlievert PM. Staphylococcus aureus beta-toxin production is common in strains with the beta-toxin gene inactivated by bacteriophage. J Infect Dis. 2014; 210(5):784-792.
9. Ortega E, Abriouel H, Lucas R and Galvez A. Multiple roles of Staphylococcus aureus enterotoxins: pathogenicity, superantigenic activity, and correlation to antibiotic resistance. Toxins (Basel). 2010; 2(8):2117-2131.
10. Umeda K, Nakamura H, Yamamoto K, Nishina N, Yasufuku K, Hirai Y, Hirayama T, Goto K, Hase A and Ogasawara J. Molecular and epidemiological characterization of staphylococcal foodborne outbreak of Staphylococcus aureus harboring seg, sei, sem, sen, seo, and selu genes without production of classical enterotoxins. Int J Food Microbiol. 2017; 256:30-35.
11. Deurenberg RH, Nieuwenhuis RF, Driessen C, London N, Stassen FR, van Tiel FH, Stobberingh EE and Vink C. The prevalence of the Staphylococcus aureus tst gene among community- and hospital-acquired strains and isolates from Wegener's Granulomatosis patients. FEMS Microbiol Lett. 2005; 245(1):185-189.
12. Grumann D, Nubel U and Broker BM. Staphylococcus aureus toxins--their functions and genetics. Infect Genet Evol. 2014; 21:583-592.
13. Alonzo F, 3rd, Kozhaya L, Rawlings SA, Reyes-Robles T, DuMont AL, Myszka DG, Landau NR, Unutmaz D and Torres VJ. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature. 2013; 493(7430):51-55.
14. von Eiff C, Friedrich AW, Peters G and Becker K. Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis. 2004; 49(3):157-162.
15. Ryden C, Tung HS, Nikolaev V, Engstrom A and Oldberg A. Staphylococcus aureus causing osteomyelitis binds to a nonapeptide sequence in bone sialoprotein. Biochem J. 1997; 327 ( Pt 3):825-829.
16. Ryden C, Yacoub AI, Maxe I, Heinegard D, Oldberg A, Franzen A, Ljungh A and Rubin K. Specific binding of bone sialoprotein to Staphylococcus aureus isolated from patients with osteomyelitis. Eur J Biochem. 1989; 184(2):331-336.
17. Yu F, Liu Y, Lv J, Qi X, Lu C, Ding Y, Li D, Liu H and Wang L. Antimicrobial susceptibility, virulence determinant carriage and molecular characteristics of Staphylococcus aureus isolates associated with skin and soft tissue infections. Braz J Infect Dis. 2015; 19(6):614-622.
18. Liu Y, Xu Z, Yang Z, Sun J and Ma L. Characterization of community-associated Staphylococcus aureus from skin and soft-tissue infections: a multicenter study in China. Emerg Microbes Infect. 2016; 5(12):e127.
19. Feng-Jui Chen T-LL, *, I-Wen Huang H-JL, * Jui-Fen Lai,*, Hui-Yin Wang Y-RS, * Pei-Chen Chen,* and Teruyo Ito aKH. Methicillin-resistant Staphylococcus aureus in Taiwan. National Center for Infectious Diseases (US). 2005.
20. Chen FJ, Hiramatsu K, Huang IW, Wang CH and Lauderdale TL. Panton-Valentine leukocidin (PVL)-positive methicillin-susceptible and resistant Staphylococcus aureus in Taiwan: identification of oxacillin-susceptible mecA-positive methicillin-resistant S. aureus. Diagn Microbiol Infect Dis. 2009; 65(4):351-357.
21. Wan TW, Hung WC, Tsai JC, Lin YT, Lee H, Hsueh PR, Lee TF and Teng LJ. Novel Structure of Enterococcus faecium-Originated ermB-Positive Tn1546-Like Element in Staphylococcus aureus. Antimicrob Agents Chemother. 2016; 60(10):6108-6114.
22. Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JM and Kreiswirth BN. spa Typing Method for Discriminating among Staphylococcus aureus Isolates: Implications for Use of a Single Marker To Detect Genetic Micro- and Macrovariation. Journal of Clinical Microbiology. 2004; 42(2):792-799.
23. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, Bost DA, Riehman M, Naidich S and Kreiswirth BN. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol. 1999; 37(11):3556-3563.
24. Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR, Persing DH and Consortium M. Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents Chemother. 2012; 56(3):1324-1330.
25. Tenover FC and Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother. 2009; 64(3):441-446.
26. Chuang YY and Huang YC. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis. 2013; 13(8):698-708.
27. Wang HK, Huang CY and Huang YC. Clinical features and molecular characteristics of childhood community-associated methicillin-resistant Staphylococcus aureus infection in a medical center in northern Taiwan, 2012. BMC Infect Dis. 2017; 17(1):470.
28. Kaneko J and Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem. 2004; 68(5):981-1003.
29. Chambers HF. Staphylococcal purpura fulminans: a toxin-mediated disease? Clin Infect Dis. 2005; 40(7):948-950.
30. Otto M. Community-associated MRSA: what makes them special? Int J Med Microbiol. 2013; 303(6-7):324-330.
31. Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse L, Peyrol S, Thivolet F, Etienne J, Lina G, Vallette FM, Vandenesch F and Genestier L. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest. 2005; 115(11):3117-3127.
32. Loffler B, Hussain M, Grundmeier M, Bruck M, Holzinger D, Varga G, Roth J, Kahl BC, Proctor RA and Peters G. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 2010; 6(1):e1000715.
33. Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, Aerts PC, Kemmink J, de Haas CJ, van Kessel KP, Vandenesch F, Lina G and van Strijp JA. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. Cell Host Microbe. 2013; 13(5):584-594.
34. Shallcross LJ, Fragaszy E, Johnson AM and Hayward AC. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2013; 13(1):43-54.
35. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME and Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003; 9(8):978-984.
36. Day SR, Moore CM, Kundzins JR and Sifri CD. Community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus virulence toward Caenorhabditis elegans compared. Virulence. 2012; 3(7):576-582.
37. Wu K, Zhang K, McClure J, Zhang J, Schrenzel J, Francois P, Harbarth S and Conly J. A correlative analysis of epidemiologic and molecular characteristics of methicillin-resistant Staphylococcus aureus clones from diverse geographic locations with virulence measured by a Caenorhabditis elegans host model. Eur J Clin Microbiol Infect Dis. 2013; 32(1):33-42.
38. Yoong P and Pier GB. Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun. 2012; 80(8):2894-2904.
39. Thammavongsa V, Kim HK, Missiakas D and Schneewind O. Staphylococcal manipulation of host immune responses. Nat Rev Microbiol. 2015; 13(9):529-543.
40. Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP and van Strijp JA. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol. 2005; 6(9):920-927.
41. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP and van Strijp JA. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med. 2004; 199(5):687-695.
42. Menestrina G. Ionic channels formed by Staphylococcus aureus alpha-toxin: voltage-dependent inhibition by divalent and trivalent cations. J Membr Biol. 1986; 90(2):177-190.
43. Ira and Johnston LJ. Sphingomyelinase generation of ceramide promotes clustering of nanoscale domains in supported bilayer membranes. Biochim Biophys Acta. 2008; 1778(1):185-197.
44. Verdon J, Girardin N, Lacombe C, Berjeaud JM and Hechard Y. delta-hemolysin, an update on a membrane-interacting peptide. Peptides. 2009; 30(4):817-823.
45. Utter B, Deutsch DR, Schuch R, Winer BY, Verratti K, Bishop-Lilly K, Sozhamannan S and Fischetti VA. Beyond the chromosome: the prevalence of unique extra-chromosomal bacteriophages with integrated virulence genes in pathogenic Staphylococcus aureus. PLoS One. 2014; 9(6):e100502.
46. Hung WC, Wan TW, Kuo YC, Yamamoto T, Tsai JC, Lin YT, Hsueh PR and Teng LJ. Molecular Evolutionary Pathways toward Two Successful Community-Associated but Multidrug-Resistant ST59 Methicillin-Resistant Staphylococcus aureus Lineages in Taiwan: Dynamic Modes of Mobile Genetic Element Salvages. PLoS One. 2016; 11(9):e0162526.
47. Carfora V, Caprioli A, Marri N, Sagrafoli D, Boselli C, Giacinti G, Giangolini G, Sorbara L, Dottarelli S, Battisti A and Amatiste S. Enterotoxin genes, enterotoxin production, and methicillin resistance in Staphylococcus aureus isolated from milk and dairy products in Central Italy. International Dairy Journal. 2015; 42:12-15.
48. Argudin MA, Mendoza MC and Rodicio MR. Food poisoning and Staphylococcus aureus enterotoxins. Toxins (Basel). 2010; 2(7):1751-1773.
49. Wang M, Zheng Y, Mediavilla JR, Chen L, Kreiswirth BN, Song Y, Yang R and Du H. Hospital Dissemination of tst-1-Positive Clonal Complex 5 (CC5) Methicillin-Resistant Staphylococcus aureus. Front Cell Infect Microbiol. 2017; 7:101.
50. Qiao Y, Ning X, Chen Q, Zhao R, Song W, Zheng Y, Dong F, Li S, Li J, Wang L, Zeng T, Dong Y, Yao K, Yu S, Yang Y and Shen X. Clinical and molecular characteristics of invasive community-acquired Staphylococcus aureus infections in Chinese children. BMC Infect Dis. 2014; 14:582.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/69839-
dc.description.abstract金黃色葡萄球菌(Staphylococcus aureus, S. aureus)屬於人體鼻腔和皮膚的常在菌叢,主要會引起人類包括皮膚、軟組織、 肺炎、心內膜炎以及菌血症等感染,依其對於methicillin抗藥與否可以分成methicillin-resistant S. aureus及methicillin-susceptible S. aureus,以感染源於可區分為healthcare-associated及community-associated ,在臨床上S. aureus為造成皮膚及軟組織感染的主要來源,而其感染後約有三成的病人有復發感染的情況,說明病人無法因先前的感染進而對於S. aureus產生良好的免疫。因此本實驗欲收集臨床上來自皮膚及軟組織感染之S. aureus探討其抗藥性及毒力等特性。
本實驗共收集來自急診及門診菌株129株,及病房91株,其中MRSA的比例分別是60%以及68%。來源為皮膚軟組織感染有172株。MRSA當中來自急診及門診的菌株其藥物敏感性較病房好,但MSSA來源對藥物敏感性的差異不大。我們針對皮膚軟組織感染菌株進行spa type 分析,其中16%為t437、12%為t037、8%為t008、4%為t189、3%為t091及t338。在MRSA當中來自急診及門診菌株54% 有攜帶pvl,來自病房的則為24%。MSSA當中來自急診及門診菌株則有17%攜帶pvl,未發現來自病房的菌株攜帶pvl。攜帶pvl的MRSA抗藥比例較低,但對於erythromycin及trimethoprim/sulfamethoxazole卻較高。我們實驗中皮膚軟組織感染的菌株大多為IEC type B,且大多數都有攜帶 hla及hld。在classical Staphylococcal enterotoxin genes中seb佔最多,而在其他SEs則為seh佔最多。發現有五株帶有tst,九株bbp 陽性菌株有四株為t091。目前只發現一株攜帶edin,未發現菌株攜帶lukM,大部分的菌株都有攜帶lukE-lukD。
此研究初步了解台大醫院皮膚及軟組織感染之S. aureus特性。結果大致和其他台灣的研究相符,但也有些許不同,其差異可能是地域上或是檢體來源的差異,但還須進一步的實驗探討。
zh_TW
dc.description.abstractStaphylococcus aureus is one of the human normal inhabitant resident microbiota. It is an important human pathogen responsible for many infectious diseases including skin and soft tissue infections (SSTIs), pneumonia, endocarditis and blood-stream infections. S. aureus will be classified as healthcare-associated or community-associated. Prevalence of methicillin-resistant S. aureus (MRSA) and its ability to resist multiple drugs has posed a serious challenge. S. aureus is one of the common infections from skin and soft tissue. Because most of the staphylococcal SSTIs has recurrence, patients do not have good immune response to the infection. Therefore, the aim of our study is to know the characterization of S. aureus isolated from skin and soft tissue infection.
We collected 129 isolates from emergency and/or outpatient and 91 isolates from hospitalized patients. Among all isolates, 172 of them are from skin and soft tissue infection. MRSA from emergency and outpatient is more sensitive than hospitalized one, but no significant difference in MSSA. In the distribution of spa types, 3% of SSTI isolates are t091 and t338, 4% is t189, 8% is t008, 12% is t037 and 16% is t437. Among MRSA, 54% of isolates from emergency and outpatient and 24% of isolates from hospitalized patient is pvl- positive. Among MSSA, 17% of isolates from emergency and outpatient and none of isolates from hospitalized patient is pvl- positive.
Despite of erythromycin and trimethoprim/sulfamethoxazole, pvl- positive MRSA is less resistant. Most of the SSTI isolates in our study are IEC type B. Most of the SSTI isolates in our study are hla- positive and hld- positive. The most frequent enterotoxin is seb in classical Staphylococcal enterotoxins and seh in other enterotoxins. Five SSTI isolates in our study are tst- positive. 4 of the 9 bbp- positive isolates are t091. We have found one isolate with edin no isolate with lukM and most of the isolates with lukE-lukD.
In this study we examined the characterization of S. aureus isolate from skin and soft tissue infection preliminary. Most of the results in our study are similar with others although there is a little difference. The geographical differences and the sample origin may cause the divergence and need more experiment to explore.
en
dc.description.provenanceMade available in DSpace on 2021-06-17T03:30:17Z (GMT). No. of bitstreams: 1
ntu-107-R03424013-1.pdf: 1165148 bytes, checksum: 49d22eb6bded8b2caf81cffd73e0705c (MD5)
Previous issue date: 2018
en
dc.description.tableofcontents誌謝 I
中文摘要 II
英文摘要 III
目錄 IV
表目錄 V
圖目錄 VI
第一章 緒論 1
第二章 研究目的 4
第三章 實驗材料及方法 5
第四章 結果 13
第五章 討論 16
第六章 附表 23
第七章 附圖 33
第八章 參考文獻 36
dc.language.isozh-TW
dc.subject皮膚及軟組織感染zh_TW
dc.subjectCA-MRSAzh_TW
dc.subject金黃色葡萄球菌zh_TW
dc.subjectMSSAzh_TW
dc.subjectMRSAzh_TW
dc.subjectskin and soft tissue infectionsen
dc.subjectStaphylococcus aureusen
dc.subjectMRSAen
dc.subjectMSSAen
dc.subjectCA-MRSAen
dc.title自皮膚及軟組織感染分離之金黃色葡萄球菌特性探討zh_TW
dc.titleCharacterization of Staphylococcus aureus isolated from skin and soft tissue infectionen
dc.typeThesis
dc.date.schoolyear106-1
dc.description.degree碩士
dc.contributor.oralexamcommittee廖淑貞(Shwu-Jen Liaw),洪薇鈞(Wei-Chun Hung)
dc.subject.keyword金黃色葡萄球菌,皮膚及軟組織感染,MRSA,MSSA,CA-MRSA,zh_TW
dc.subject.keywordStaphylococcus aureus,skin and soft tissue infections,MRSA,MSSA,CA-MRSA,en
dc.relation.page40
dc.identifier.doi10.6342/NTU201800479
dc.rights.note有償授權
dc.date.accepted2018-02-22
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept醫學檢驗暨生物技術學研究所zh_TW
顯示於系所單位:醫學檢驗暨生物技術學系

文件中的檔案:
檔案 大小格式 
ntu-107-1.pdf
  未授權公開取用
1.14 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved